Citi maintains buy on CSL after mammoth takeover
MELBOURNE: Citi analysts have maintained their ‘buy’ rating on biotech giant CSL, noting ... read more
Tilray expands medical cannabis product offering in Australia
SYDNEY: Tilray Brands, Inc., a global cannabis-lifestyle and consumer packaged goods company inspiring ... read more
EBOS lifts raising to $161m after significant support
MELBOURNE: EBOS, an ASX-listed healthcare and animal care product distributor, has increased its ... read more
